Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up

por Ponder, B
Publicado 2000

Genetic predisposition to cancer.

por Ponder, B. A.
Publicado 1991

Polyclonal origin of mouse skin papillomas.

por Winton, D. J., Blount, M. A., Ponder, B. A.
Publicado 1989

Genetic susceptibility to naevi--a twin study.

por Easton, D. F., Cox, G. M., Macdonald, A. M., Ponder, B. A.
Publicado 1991

The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.

por Dowsett, M., Shearer, R. J., Ponder, B. A., Malone, P., Jeffcoate, S. L.
Publicado 1988

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

por Papp, J., Csokay, B., Bosze, P., Zalay, Z., Toth, J., Ponder, B., Olah, E.
Publicado 1996

A prospective study of neurofibromatosis type 1 cancer incidence in the UK

por Walker, L, Thompson, D, Easton, D, Ponder, B, Ponder, M, Frayling, I, Baralle, D
Publicado 2006

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer

por Unoki, M, Kelly, J D, Neal, D E, Ponder, B A J, Nakamura, Y, Hamamoto, R
Publicado 2009

Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.

por Eng, C., Foster, K. A., Healey, C. S., Houghton, C., Gayther, S. A., Mulligan, L. M., Ponder, B. A.
Publicado 1996

Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas.

por de Foy, K. A., Gayther, S. A., Colledge, W. H., Crockett, S., Scott, I. V., Evans, M. J., Ponder, B. A.
Publicado 1998

Common germ-line polymorphism of C1QA and breast cancer survival

por Azzato, E M, Lee, A J X, Teschendorff, A, Ponder, B A J, Pharoah, P, Caldas, C, Maia, A T
Publicado 2010

Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

por Ponder, B. A., Shearer, R. J., Pocock, R. D., Miller, J., Easton, D., Chilvers, C. E., Dowsett, M., Jeffcoate, S. L.
Publicado 1984

Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.

por Nagai, M. A., Pacheco, M. M., Brentani, M. M., Marques, L. A., Brentani, R. R., Ponder, B. A., Mulligan, L. M.
Publicado 1994

Interactions between genes involved in the antioxidant defence system and breast cancer risk

por Oestergaard, M Z, Tyrer, J, Cebrian, A, Shah, M, Dunning, A M, Ponder, B A J, Easton, D F, Pharoah, P D P
Publicado 2006

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours

por Özdağ, H, Batley, S J, Försti, A, Iyer, N G, Daigo, Y, Boutell, J, Arends, M J, Ponder, B A J, Kouzarides, T, Caldas, C
Publicado 2002

Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population

por Lesueur, F, Song, H, Ahmed, S, Luccarini, C, Jordan, C, Luben, R, Easton, D F, Dunning, A M, Pharoah, P D, Ponder, B A J
Publicado 2006

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

por Antoniou, A C, Pharoah, P D P, McMullan, G, Day, N E, Stratton, M R, Peto, J, Ponder, B J, Easton, D F
Publicado 2002

Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese

por Hu, S P, Day, N E, Li, D R, Luben, R N, Cai, K L, Ou-Yang, T, Li, B, Lu, X Z, Ponder, B A J
Publicado 2005

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.

por Dunning, A. M., Healey, C. S., Pharoah, P. D., Foster, N. A., Lipscombe, J. M., Redman, K. L., Easton, D. F., Day, N. E., Ponder, B. A.
Publicado 1998

Mutation testing in melanoma families: INK4A, CDK4 and INK4D

por Newton Bishop, J A, Harland, M, Bennett, D C, Bataille, V, Goldstein, A M, Tucker, M A, Ponder, B A J, Cuzick, J, Selby, P, Bishop, D T
Publicado 1999